$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - CYTH, ALVR, WMPN, OMC
Werte in diesem Artikel
NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:
• Cyclo Therapeutics, Inc. (Nasdaq: CYTH), relating to its proposed merger with Rafael Holdings, Inc. Under the terms of the agreement, Cyclo common stock will automatically be converted into the right to receive shares of Rafael common stock.
Click here for more information https://monteverdelaw.com/case/cyclo-therapeutics-inc/. It is free and there is no cost or obligation to you.
• AlloVir, Inc. (NASDAQ: ALVR), relating to its proposed merger with Kalaris Therapeutics. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris. Upon completion of the Merger, pre-Merger AlloVir stockholders are expected to own approximately 25.05% of the combined company and pre-Merger Kalaris stockholders are expected to own approximately 74.95% of the combined company.
Click here for more information https://monteverdelaw.com/case/allovir-inc-alvr/. It is free and there is no cost or obligation to you.
• William Penn Bancorporation (Nasdaq: WMPN), relating to its proposed merger with Mid Penn Bancorp, Inc. Under the terms of the agreement, shareholders of William Penn will receive 0.4260 shares of Mid Penn common stock for each share of William Penn common stock. Additionally, all options of William Penn will be rolled into Mid Penn equivalent options. The implied transaction value is approximately $13.58 per William Penn share.
Click here for more information https://monteverdelaw.com/case/william-penn-bancorporation-wmpn/. It is free and there is no cost or obligation to you.
• Omnicom Group Inc. (NYSE: OMC), relating to the proposed merger with The Interpublic Group of Companies, Inc. Under the terms of the agreement, Omnicom shareholders will own 60.6% of the combined company.
Click here for more https://monteverdelaw.com/case/omnicom-group-inc-omc/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE Monteverde & Associates PC
Ausgewählte Hebelprodukte auf AlloVir
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AlloVir
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Omnicom Group Inc.
Analysen zu Omnicom Group Inc.
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Omnicom Group Market Perform | BMO Capital Markets | |
17.04.2019 | Omnicom Group Equal Weight | Barclays Capital | |
16.10.2018 | Omnicom Group Hold | Pivotal Research Group | |
03.04.2018 | Omnicom Group Hold | Pivotal Research Group | |
16.02.2018 | Omnicom Group Outperform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Omnicom Group Market Perform | BMO Capital Markets | |
16.02.2018 | Omnicom Group Outperform | BMO Capital Markets | |
18.10.2017 | Omnicom Group Outperform | RBC Capital Markets | |
18.10.2017 | Omnicom Group Outperform | Telsey Advisory Group | |
08.03.2017 | Omnicom Group Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
17.04.2019 | Omnicom Group Equal Weight | Barclays Capital | |
16.10.2018 | Omnicom Group Hold | Pivotal Research Group | |
03.04.2018 | Omnicom Group Hold | Pivotal Research Group | |
16.02.2018 | Omnicom Group Sector Perform | RBC Capital Markets | |
15.02.2018 | Omnicom Group Hold | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
13.04.2015 | Omnicom Group Sell | Pivotal Research Group | |
08.11.2007 | Omnicom Group sell | Banc of America Sec. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicom Group Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen